A carregar...
Cabozantinib for the treatment of kidney cancer
INTRODUCTION: Cabozantinib is a small molecule tyrosine kinase inhibitor that initially showed activity in medullary thyroid cancer and was recently approved by the Food and Drug Administration for the treatment of metastatic renal cell carcinoma after progression on first line therapy. AREAS COVERE...
Na minha lista:
| Publicado no: | Expert Rev Anticancer Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6166873/ https://ncbi.nlm.nih.gov/pubmed/28633552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737140.2017.1344553 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|